Evidence map›Paper›PMID 29278358›Full record

ArticleNutrients2017

Characterisation of L-Type Amino Acid Transporter 1 (LAT1) Expression in Human Skeletal Muscle by Immunofluorescent Microscopy.

Nathan Hodson, Thomas Brown, Sophie Joanisse, Nick Aguirre, Daniel W D West, Daniel R Moore, Keith Baar, Leigh Breen, Andrew Philp

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. The Lancet. Oncology · 2019
    Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Nathan HodsonSchool of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham B15 2TT, UK. NWH151@student.bham.ac.uk.
Thomas BrownSchool of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham B15 2TT, UK. txb208@alumni.bham.ac.uk.
Sophie JoanisseSchool of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham B15 2TT, UK. S.Joanisse@bham.ac.uk.
Nick AguirreUniversity of California Davis, Davis, CA 95616, USA. nwaguirre@ucdavis.edu.
Daniel W D WestFaculty of Kinesiology and Physical Education, University of Toronto, Toronto, ON M5S 1A1, Canada. daniel.west@utoronto.ca.
Daniel R MooreFaculty of Kinesiology and Physical Education, University of Toronto, Toronto, ON M5S 1A1, Canada. dr.moore@utoronto.ca.
Keith BaarUniversity of California Davis, Davis, CA 95616, USA. kbaar@ucdavis.edu.
Leigh BreenSchool of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham B15 2TT, UK. l.breen@bham.ac.uk.ORCID 0000-0001-6669-4816
Andrew PhilpSchool of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham B15 2TT, UK. a.philp@bham.ac.uk.
University of Birmingham · GBUniversity of California, Davis · USUniversity of Toronto · CA

Funding

UC Davis MCB T32 Administrative Supplement to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) MentorshipT32GM007377 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI CHEDIN, FREDERIC LOUIS · 1985 to 2023
$9.9M
LAT1 and the development of anabolic resistanceR01AG045375 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAAR, KEITH · 2014 to 2018
$1.7M
NIA NIH HHS R01 AG045375NIGMS NIH HHS T32 GM007377
6 · The paper itself

Abstract

The branch chain amino acid leucine is a potent stimulator of protein synthesis in skeletal muscle. Leucine rapidly enters the cell via the L-Type Amino Acid Transporter 1 (LAT1); however, little is known regarding the localisation and distribution of this transporter in human skeletal muscle. Therefore, we applied immunofluorescence staining approaches to visualise LAT1 in wild type (WT) and LAT1 muscle-specific knockout (mKO) mice, in addition to basal human skeletal muscle samples. LAT1 positive staining was visually greater in WT muscles compared to mKO muscle. In human skeletal muscle, positive LAT1 staining was noted close to the sarcolemmal membrane (dystrophin positive staining), with a greater staining intensity for LAT1 observed in the sarcoplasmic regions of type II fibres (those not stained positively for myosin heavy-chain 1, Type II-25.07 ± 5.93, Type I-13.71 ± 1.98,

Indexed as

Fluorescent Antibody TechniqueMicroscopy, FluorescenceAmino Acid Transport System y+Amino Acid Transport System y+LAnimalsFusion Regulatory Protein 1, Light ChainsHumansMaleMice, KnockoutMuscle Fibers, Fast-TwitchMuscle Fibers, Slow-TwitchNitric Oxide Synthase Type IIIQuadriceps MuscleSarcolemmaYoung AdultAmino Acid Transport System y+Amino Acid Transport System y+LFusion Regulatory Protein 1, Light ChainsNitric Oxide Synthase Type IIINOS3 protein, humanSLC7A7 protein, humanSlc7a7 protein, mouseamino acid transportLAT1leucineprotein

Identifiers

PMID29278358
PMCPMC5793251
OpenAlexW2779374474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.